Elon Musk Loses Ground in OpenAI Trial Drama

Reporting by CNN, NBC, CNBC, Slate and the Wall Street Journal documents that Elon Musk took the witness stand this week in a federal jury trial he filed against OpenAI and co-founders Sam Altman and Greg Brockman.

Per Slate, Musk is seeking more than $130 billion in damages and wants Altman and Brockman removed from the company; CNBC reports Musk testified he contributed roughly $38 million to the organisation. Slate and WSJ quoted Musk as telling jurors, "It is not OK to steal a charity," and warning the outcome could threaten charities broadly. CNBC and other outlets reported that Microsoft made a $10 billion investment referenced during testimony.

Multiple outlets, including NBC and CNN, describe Musk as combative during cross-examination and note heated exchanges with OpenAI counsel William Savitt. Reporting shows Musk left OpenAI's board in 2018, a fact cited in CNBC and CNN coverage. Slate and others reported the parties have deployed large legal teams and that the litigation is burning substantial legal budgets as it proceeds.

Industry observers: Founder-origin disputes over governance and capital structure are not new in tech, and public litigation of this scale produces extensive discovery that can expose internal strategy, fundraising terms, and communications. Companies involved in frontier AI development typically require large external capital commitments to train state-of-the-art models; public lawsuits that target corporate structure and fundraising arrangements can therefore reshape investor due diligence and conditional investment language across the sector.

Editorial analysis: This trial combines legal, governance, and reputational dimensions that matter to AI practitioners and investors. Reported allegations concern nonprofit-to-profit conversions and the use of donated funds, which implicates legal precedent for charitable trusts and corporate governance when research labs accept both philanthropic and commercial capital. Observers tracking AI governance will watch whether juries accept claims that charitable commitments were violated, because such outcomes could alter how research organisations structure funding vehicles and donor agreements.

Editorial analysis: Key indicators to follow, as derived from public reporting, include the jury's response to documentary evidence disclosed in discovery, any testimony from Microsoft or other investors about deal terms, and whether the court entertains remedies beyond monetary damages, such as structural or governance changes. Observers should also track knock-on effects in term sheets and nonprofit oversight for AI research groups.

Editorial analysis: Firms and labs that blend philanthropic support with venture-style capital will likely see renewed scrutiny of donor agreements and governance charters. Legal disputes of this scale divert executive attention and resources, and they can slow collaboration, hiring, and fundraising even without a definitive verdict. For practitioners, the immediate implications are increased legal diligence around funding instruments and more careful documentation of board decisions and donor expectations.

All factual claims in this summary are drawn from contemporaneous reporting by Slate, NBC, CNBC, CNN and the Wall Street Journal, and aggregated coverage in The New York Times, CBS News, The Guardian and regional outlets referenced in public summaries. Where direct quotes are used, they are taken verbatim from those sources.